Dietary Supplement
B12
B12 is a dietary supplement with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
1
17%
Ph phase_4
2
33%
Ph phase_3
2
33%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (40.0%)
Phase 42 (40.0%)
N/A1 (20.0%)
Trials by Status
unknown233%
active_not_recruiting117%
completed350%
Recent Activity
1 active trials
Showing 5 of 6
active_not_recruitingphase_3
Combination Gerotherapeutic Interventions for Healthspan Improvement
NCT07475546
unknownphase_4
Management of Preoperative Anaemia in Surgical Oncology
NCT05505006
unknown
Vascular and Metabolic Changes in Postmenopausal Diabetics
NCT03273738
completedphase_3
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
NCT00806819
completednot_applicable
Treating Oxidative Stress and the Metabolic Pathology of Autism
NCT00572741
Clinical Trials (6)
Showing 6 of 6 trials
NCT07475546Phase 3
Combination Gerotherapeutic Interventions for Healthspan Improvement
NCT05505006Phase 4
Management of Preoperative Anaemia in Surgical Oncology
NCT03273738
Vascular and Metabolic Changes in Postmenopausal Diabetics
NCT00806819Phase 3
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC
NCT00572741Not Applicable
Treating Oxidative Stress and the Metabolic Pathology of Autism
NCT00611806Phase 4
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia
All 6 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 6